Company intelligence / Profile preview

Biolog-id

Boulogne-Billancourt, Île-de-France, Francebiolog-id.com ↗

Ownership: Private
Employees: ~125
Development stage: Commercial

Overview

Biolog-id’s RFID-enabled digital health solutions are commercially deployed in North America, Europe, Middle East, India, and Asia Pacific. Their platforms improve traceability and operational efficiency in the handling of blood components, plasma for fractionation, injectable chemotherapies, and parenteral nutrition. The company has been recognized with innovation partnerships such as with the French Blood Establishment (EFS), validating its impact at scale. Clinical results per se are not relevant as this is a medtech/software company.

Modalities: DeviceSoftware Platform (RFID-based traceability and management solutions for blood products, plasma, chemotherapy drugs)
Industry: Digital Health Medical Devices

Partnerships

Établissement Français du Sang (EFS) – French Blood Establishment

Beyond the preview

Go deeper on Biolog-id.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biolog-id.

Explore the full profile